1. J. Ferlay, I. Soerjomataram, M. Ervik, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, D.M. Parkin, D. Forman, F. Bray, GLOBOCAN 2012 v1. 0, cancer incidence and mortality worldwide: IARC CancerBase No. 11, Lyon, Fr. Int. Agency Res. Cancer. 2016 (2013).
2. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n= 4532);Montopoli;Ann. Oncol.,2020
3. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor;Hoffmann;Cell,2020
4. Epidemiology, etiology, diagnosis and treatment of prostate cancer;Daniyal;Asian Pac. J. Cancer Prev.,2014
5. Mechanisms of resistance in castration-resistant prostate cancer (CRPC);Chandrasekar;Transl. Androl. Urol.,2015